318 filings
8-K
LSTA
Lisata Therapeutics Inc
9 May 24
Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
4:08pm
8-K
LSTA
Lisata Therapeutics Inc
17 Apr 24
Departure of Directors or Certain Officers
4:04pm
8-K
LSTA
Lisata Therapeutics Inc
29 Feb 24
Lisata Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
4:09pm
8-K
LSTA
Lisata Therapeutics Inc
2 Nov 23
Lisata Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:10pm
8-K
LSTA
Lisata Therapeutics Inc
14 Aug 23
Lisata Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
4:08pm
8-K
173sutrsn ckp7gu1b2
11 Jul 23
Lisata Therapeutics Announces Retirement of Dr. Erkki Ruoslahti from Board of Directors
4:01pm
8-K
wgygczyymbb2yc oq
14 Jun 23
Submission of Matters to a Vote of Security Holders
5:05pm
8-K
nsj352 asfwqihn5uhqa
9 May 23
Lisata Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:08pm
8-K
dpgi6e3o
1 May 23
Departure of Directors or Certain Officers
4:01pm
8-K
48t8u i41jxsdw9
30 Mar 23
Lisata Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
4:07pm
8-K
o6gttrminll6e3j
6 Feb 23
Results of Operations and Financial Condition
4:02pm
8-K
5tke7qij 44gw
10 Nov 22
Lisata Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
4:10pm
8-K/A
s4ydx p40vu46vie
14 Oct 22
Financial Statements and Exhibits
4:01pm
8-K/A
9w0um3dnd6tnv9p b208
4 Oct 22
Other Events
4:42pm
8-K
bqdxc4jqpw15x3l jva
29 Sep 22
Other Events
4:01pm
8-K
0exoie
22 Sep 22
Regulation FD Disclosure
4:02pm
8-K
hj7sjt not
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
8-K
69koramlag1 clbr1
14 Sep 22
Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics
5:01pm
8-K
eoks 1r62ni
19 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:33pm
8-K
6c74iz3uz1sn
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm